Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone sustained-release titration regimens for cancer pain
ChiCTR1800017461Phase 4Not yet recruiting
- Sponsor
- Xuzhou Central Hospital
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oxycodone in cancer pain (2 arms), sponsored by Xuzhou Central Hospital. Primary endpoint: Pain relief rate at 24 hours. Planned start Aug 2018; status: not yet recruiting.
02
Drugs
oxycodone
03
Conditions
cancer pain
Beyond the preview
Go deeper on ChiCTR1800017461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017461.